BY AND BETWEENManufacturing and Supply Agreement • November 9th, 2007 • Xanodyne Pharmaceuticals Inc • North Carolina
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • October 2nd, 2023 • New York
Voortrekker Rd, Pretoria Townlands 351-JR, Pretoria, 0187 (hereinafter "Purchaser"). Purchaser and Pfizer may be referred to herein individually as a "Party" or collectively as the "Parties".
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • September 26th, 2016 • ViewRay, Inc. • Electromedical & electrotherapeutic apparatus • New York
This Manufacturing and Supply Agreement (“Agreement”) is entered into as of September 18th, 2013 (“Effective Date”) by and between ViewRay Incorporated, a Delaware corporation (“ViewRay”), and Japan Superconductor Technology, Inc., a corporation organized under the laws of Japan (“Jastec”). ViewRay and Jastec may each be referred to hereafter as a “party” or collectively as the “parties.”
MANUFACTURING AND SUPPLY AGREEMENT [DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension]Manufacturing and Supply Agreement • September 27th, 2012 • Lantheus Medical Imaging, Inc. • Pharmaceutical preparations • New York
This Manufacturing and Supply Agreement (this “Agreement”), dated as of February 1, 2012 (the “Effective Date”), is hereby entered into by and between Lantheus Medical Imaging, Inc., a corporation organized and existing under the laws of Delaware with its principal place of business at 331 Treble Cove Road, North Billerica, MA 01862 (“LMI”), and Jubilant HollisterStier LLC, a limited liability company organized and existing under the laws of Delaware with a place of business at 3525 North Regal Street, Spokane, Washington, 99207 (“HSL”). LMI and HSL are referred to herein individually as a “Party” and collectively as the “Parties”.
MANUFACTURING AND SUPPLY AGREEMENT BY AND BETWEEN PFIZER INC. AND UPJOHN INC. DATED AS OF NOVEMBER 16, 2020Manufacturing and Supply Agreement • November 19th, 2020 • Viatris Inc • Pharmaceutical preparations • Delaware
THIS MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), dated as of November 16, 2020 (the “Effective Date”), is by and between Pfizer Inc., a Delaware corporation (hereinafter “Manufacturer”), and Upjohn Inc., a Delaware corporation (hereinafter “Customer”). Manufacturer and Customer may be referred to herein individually as a “Party” or collectively as the “Parties”.
MANUFACTURING AND SUPPLY AGREEMENT relating to the separation of the Alcon surgical and vision care business Puurs/Barcelona/BrazilManufacturing and Supply Agreement • April 9th, 2019 • Alcon Inc • Ophthalmic goods
ContractManufacturing and Supply Agreement • May 5th, 2020 • New York
EX-10.9 14 srmexhibit109s-1.htm EXHIBIT 10.9 Exhibit 10.9 EXECUTION VERSION AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT This Amended and Restated Manufacturing and Supply Agreement (this “Agreement”) is entered into as of January 10, 2018 (the “Amendment Effective Date”), by and between Silk Road Medical, Inc., a corporation duly organized and existing under the laws of the State of Delaware and having its principal office at 735 North Pastoria Avenue, Sunnyvale, CA 94085 (“Silk Road Medical”), and Galt Medical Corporation, a Texas corporation having a place of business at 2220 Merritt Drive, Garland, Texas 75041 (“Supplier”), and amends and restates in its entirety that certain Manufacturing and Supply Agreement, effective as of September 18, 2014 (the “Effective Date”), by and between the Parties (the “Original Agreement”). Each of Silk Road Medical and Supplier is referred to herein by name or as a “Party,” and, collectively, as the “Parties.” RECITALS WHEREAS, Supplier
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • November 12th, 2019 • Delaware
This MANUFACTURING AND SUPPLY AGREEMENT ("Agreement") is made as of this 28th day of June, 2006, (the "Effective Date") by and between ASTRAZENECA, LP, a Delaware limited partnership having a principal place of business at 1800 Concord Pike, Wilmington, Delaware, 19850, ("AZ") and ABRAXIS BIOSCIENCE, INC., a Delaware corporation having a place of business at 11777 San Vincente Blvd., Suite 550, Los Angeles, CA 90049 ("ABBI").
EX-10.65 3 dex1065.htm MANUFACTURING AND SUPPLY AGREEMENT BETWEEN SALIX AND GLENMARK * Portions of this document marked [*] are requested to be treated confidentially. EXECUTION COPY MANUFACTURING AND SUPPLY AGREEMENT between SALIX PHARMACEUTICALS,...Manufacturing and Supply Agreement • May 5th, 2020 • New York
This MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), dated as of December 9, 2008 (the “Effective Date”), is made by and between Salix Pharmaceuticals, Inc., a Delaware corporation (“Salix”), and Glenmark Pharmaceuticals Ltd., a corporation organized under the laws of India (“Glenmark”). Salix and Glenmark are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Exhibit 10.47 MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement ("Agreement") is entered into as of the date signed by the last party to sign this Agreement, and with an effective date of February 8, 2006 (the "Effective...Manufacturing and Supply Agreement • April 3rd, 2006 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • Delaware
EX-10.101 4 g94931exv10w101.htm MANUFACTURING AND SUPPLY AGREEMENT MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • May 5th, 2020 • New York
This Manufacturing and Supply Agreement (this “Agreement”) is effective as of March 28, 2005 (the “Effective Date”), by and between First Horizon Pharmaceutical Corporation, a Delaware corporation with its principal place of business located at 6195 Shiloh Road, Alpharetta, Georgia 30005 (“Purchaser”) and Andrx Pharmaceuticals, Inc., a Florida corporation with its principal office located at 4955 Orange Drive, Davie, Florida 33314 (“Andrx”).
EX-10.23 24 filename24.htm ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 230.406 MANUFACTURING AND SUPPLY AGREEMENT effective as of this 9...Manufacturing and Supply Agreement • May 5th, 2020 • New York
WHEREAS, GW is a company engaged in the processing and supply of pharmaceutical products holding the necessary manufacturing licenses and permits in this respect;
MANUFACTURING AND SUPPLY AGREEMENT FOR TRANSDERMAL FENTANYLManufacturing and Supply Agreement • March 24th, 2014 • Corium International, Inc. • Pharmaceutical preparations • Florida
THIS MANUFACTURING AND SUPPLY AGREEMENT (the “Agreement”) is made as of November 12th, 2003 (the “Effective Date”), by and between Abrika LLLP, a Florida limited liability limited partnership (“Abrika”), with offices at 13800 N.W. 2nd St., Suite 190, Florida 33325 and Corium International, Inc., a Delaware corporation having a place of business at 2686 Middlefield Road, Suite G, Redwood City, CA 94063 (“Corium”; together with Abrika, the “Parties”).
RECITALSManufacturing and Supply Agreement • December 23rd, 2003 • Santarus Inc
EX-10.12 18 a2236601zex-10_12.htm EX-10.12Manufacturing and Supply Agreement • May 5th, 2020
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
EX-10.30 8 dex1030.htm MANUFACTURING AND SUPPLY AGREEMENT ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406. DATED NOVEMBER 4, 2010...Manufacturing and Supply Agreement • May 5th, 2020
CONFIDENTIAL- CONFIDENCIAL CONFIDENTIAL- CONFIDENCIALManufacturing and Supply Agreement • December 2nd, 2022 • New York
THIS MANUFACTURING AND SUPPLYAGREEMENT dated as of February 2, 2021 (the “Effective Date”) is made by and between PFIZER EXPORT BV with offices at Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Netherlands (hereinafter “Pfizer”) and Fiduprevisora S.A., as the legal representative and administrator of the Autonomous Patrimony of the National Fund for Disaster Risk Management – Subaccount for the mitigation of emergencies COVID -19 (“FNGRD”) acting as instructed by the Director of the National Disaster and Risk Management Unit (UNGRD), (hereinafter “Purchaser”). Purchaser and Pfizer may be referred to herein individually as a “Party” or collectively as the “Parties”. ESTE ACUERDO DE FABRICACIÓN YSUMINISTRO de fecha 2 de febrero de 2021 (la “Fecha Efectiva”) se celebra entre PFIZER EXPORT BV con domicilio en Rivium Westlaan 142, 2909LD, Capelle aan den Ijssel, Holanda (en adelante, “Pfizer”) y Fiduprevisora S.A. como representante legal y administradora del Patrimonio Autónomo del
AMENDMENT NO.1 TO A MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 2nd, 2021 • SOPHiA GENETICS SA • Biological products, (no disgnostic substances) • Delaware
WHEREAS The Parties entered into an “Amended and Restated Manufacturing and Supply Agreement” on October 9th, 2018 (the “Main Agreement”);
RECITALSManufacturing and Supply Agreement • August 12th, 2002 • Allergan Inc • Pharmaceutical preparations • California
EX-10.2 3 a17-10836_1ex10d2.htm EX-10.2Manufacturing and Supply Agreement • May 5th, 2020 • New York
[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
ContractManufacturing and Supply Agreement • May 5th, 2020 • California
EX-10.10 22 a54842orexv10w10.htm EX-10.10 EXHIBIT 10.10 B35 MANUFACTURING AND SUPPLY AGREEMENT This Manufacturing and Supply Agreement (this “Agreement”) is entered into as of January 30, 2010 (the “Effective Date”) by and between FALLBROOK TECHNOLOGIES INC. or its designee, a Delaware corporation with a place of business at 9444 Waples St., Suite 410, San Diego, California 92121, U.S.A. (“Fallbrook”), and TRI STAR GROUP, a China a place of business at 11G, 720 PUDONG AVE, Shanghai, China 200120 (“TSI”). RECITALS WHEREAS, the parties have executed that certain B35 Program Agreement between as of November 24, 2009 (the “Original Agreement”) and intend to revoke that agreement and replace it with a more complete understanding of terms of a manufacturing arrangement; WHEREAS, the parties desire that TSI manufacture the Product (as defined below) in quantities ordered by Fallbrook and for sale by Fallbrook in the Fallbrook Territory (as defined below); and WHEREAS, the parties also desire
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 23rd, 2007 • Baywood International Inc • Medicinal chemicals & botanical products • California
This Manufacturing and Supply Agreement (this “Agreement”) is effective as of the 30th day of March, 2007 (the “Effective Date”), by and between Baywood International, Inc., a Nevada corporation (“Customer”), and Ultimate Formulations, Inc. dba Best formulations, a California corporation (“Supplier”). In consideration of the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • November 12th, 2021 • Flexion Therapeutics Inc • Pharmaceutical preparations
This MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) dated as of July 31, 2015 (the “Effective Date”) is made by and between Flexion Therapeutics, Inc., a Delaware corporation having its principal place of business at 10 Mall Road, Suite 301, Burlington, Massachusetts, United States (“Flexion”) and Patheon UK Limited, a company incorporated in England and Wales having its principal place of business at Kingfisher Drive, Covingham, Swindon, SN35BZ, United Kingdom (“Patheon”). Flexion, and Patheon are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
EX-10.8 27 dex108.htm MANUFACTURING AND SUPPLY AGREEMENT MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • May 5th, 2020 • California
This MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), effective as of December 22, 2005 (the “Effective Date”), is made by and between NeurogesX Inc., a Delaware corporation having a principal place of business at San Carlos Business Park, 981F Industrial Road, San Carlos, California 94070 U.S.A. (“NeurogesX”), and Contract Pharmaceuticals Limited Canada, an Ontario corporation having a principal place of business at 7600 Danbro Crescent, Mississauga, Ontario Canada, L5N 6L6 (“CPL”). NeurogesX and CPL may be referred to herein each, individually, as a “Party” or, collectively, as the “Parties”.
EX-10.1 2 d338151dex101.htm MANUFACTURING AND SUPPLY AGREEMENT MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • May 5th, 2020 • California
This Manufacturing and Supply Agreement (the “Agreement”) effective as of March 21, 2012 (the “Effective Date”) is entered into by and between Corcept Therapeutics Incorporated, a Delaware corporation located at 149 Commonwealth Drive, Menlo Park, CA 94025 (“Corcept”) and Formulation Technologies, LLC D/B/A PharmaForm, LLC a Texas Limited Liability corporation located at 11501 Domain Drive, Suite 130, Austin, TX 78758 (“PharmaForm”). Corcept and PharmaForm are sometimes referred to individually as a “Party” and collectively as the “Parties”.
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • June 13th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Georgia
THIS MANUFACTURING AND SUPPLY AGREEMENT (the “Agreement”) is made and entered into this 6 day of June, 2003 (the “Effective Date”), by and between TEAMM PHARMACEUTICALS, INC. (“TEAMM”) and MIKART, INC. (“Mikart”). Mikart is a Georgia corporation with its principal place of business at 1750 Chattahoochee Avenue, Atlanta, Georgia 30318. TEAMM is a Florida corporation with its principal place of business at 3000 Aerial Center Parkway, Suite 110, Morrisville, North Carolina 27560.
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • July 17th, 2018 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • Texas
This Manufacturing and Supply Agreement (this “Agreement”) is entered into as of the Effective Date (as defined below) by and between (1) Apollo Endosurgery, Delaware corporation having offices at 1120 S Capital of Texas Highway #300, Austin, TX 78746 (“APOLLO”), and (2) Establishment Labs, S.A a corporation organized under the laws of Costa Rica and having a principal place of business at Coyol Free Zone, B15, Alajuela, 20113, Costa Rica (“ESTABLISHMENT”). APOLLO and ESTABLISHMENT shall hereinafter be individually referred to as a “Party” and collectively as the “Parties.”
ELANCO UK AH LIMITED AND ELI LILLY EXPORT S.A.Manufacturing and Supply Agreement • August 28th, 2018 • Elanco Animal Health Inc • Pharmaceutical preparations
THIS TOLL MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), dated as of [•], 2018 (the “Effective Date”), is entered into by and between Elanco UK AH Limited, a corporation organized under the laws of the United Kingdom (the “Supplier”), and Eli Lilly Export S.A., a company organized under the laws of Switzerland (the “Purchaser”) (Supplier and Purchaser hereinafter referred to individually as a “Party” or collectively as the “Parties”).
MANUFACTURING AND SUPPLY AGREEMENT dated as of June 30, 2015 by and between BAXTER INTERNATIONAL INC. and BAXALTA INCORPORATEDManufacturing and Supply Agreement • July 2nd, 2015 • Baxalta Inc • Pharmaceutical preparations
THIS MANUFACTURING AND SUPPLY AGREEMENT (together with each of the Schedules and Exhibits hereto, and each Joinder Agreement executed in connection herewith, this “Agreement”), dated as of June 30, 2015, is by and between Baxter International Inc., a Delaware corporation (“Baxter”), Baxalta Incorporated, a Delaware corporation (“Baxalta”) and each of their respective Subsidiaries (as defined in the Separation Agreement) that execute a Joinder Agreement (as defined herein) in accordance with the terms and conditions of this Agreement.
AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • March 7th, 2014 • Cerus Corp • Surgical & medical instruments & apparatus • Illinois
THIS AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is entered into by and between FENWAL, INC., a company organized under the laws of Delaware (“Fenwal”), and CERUS CORPORATION, a company organized under the laws of Delaware (“Cerus”). Fenwal and Cerus, as corporations, are sometimes referred to herein as a “Party” and collectively as the “Parties.” This Agreement shall become effective as of the last date of signature by the Parties (the “Effective Date”).
ContractManufacturing and Supply Agreement • May 14th, 2021 • Roivant Sciences Ltd. • Delaware
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE DERMAVANT SCIENCES LTD. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO DERMAVANT SCIENCES LTD. IF PUBLICLY DISCLOSED.
ContractManufacturing and Supply Agreement • May 14th, 2021 • Roivant Sciences Ltd. • Delaware
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE DERMAVANT SCIENCES LTD. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO DERMAVANT SCIENCES LTD. IF PUBLICLY DISCLOSED.
MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • June 26th, 2015 • Amplify Snack Brands, INC • Food and kindred products • Illinois
This MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is dated as of February 27, 2014 (the “Effective Date”), between SKINNYPOP POPCORN LLC, a limited liability company organized under the laws of Illinois, (“Buyer”) and ASSEMBLERS FOOD PACKAGING LLC, a limited liability company organized under the laws of the state of Illinois (“Manufacturer” and together with Buyer, the “Parties”).
MANUFACTURING AND SUPPLY AGREEMENT between INTERCEPT PHARMA EUROPE LTD. and PHARMAZELL GMBHManufacturing and Supply Agreement • February 25th, 2021 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), dated the last date of signature (the “Effective Date”), is made by and between Intercept Pharma Europe Ltd., having a location at 2 Pancras Square, Floor 1, London, United Kingdom N1C 4AG (“Intercept”), and, solely for purposes of Section 10.19, Intercept Pharmaceuticals, Inc. (“Intercept Parent”), and PharmaZell GmbH, a corporation organized under the laws of Germany (“PharmaZell”). Intercept and PharmaZell are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. MANUFACTURING AND SUPPLY AGREEMENTManufacturing and Supply Agreement • June 23rd, 2017 • Kala Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS MANUFACTURING AND SUPPLY AGREEMENT (“Agreement”), is effective on January 10th 2017 (the “Effective Date”), by and between KALA PHARMACEUTICALS, INC., a Delaware corporation with a principal place of business at 100 Beaver St., #201, Waltham, Massachusetts 02453, USA (“Kala”) and CHEMO IBERICA SA, a Spanish company with a principal place of business at Gran Via Carlos III, 98, Planta 7, 08028, Barcelona (Spain) (“Supplier”).
